AC
MDT icon

AlphaCore Capital’s Medtronic MDT Stock Holding History

AlphaCore Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
21,126
+3,242
+18% +$262K 0.03% 352
2026
Q1 		$1.56M Sell
17,884
-3,104
-15% -$297K 0.04% 298
2025
Q4 		$2.02M Buy
20,988
+11,524
+122% +$1.12M 0.05% 273
2025
Q3 		$908K Buy
9,464
+3,299
+54% +$303K 0.03% 318
2025
Q2 		$535K Buy
6,165
+326
+6% +$27.6K 0.02% 363
2025
Q1 		$529K Buy
+5,839
New +$522K 0.04% 258

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AlphaCore Capital's MDT Position: Q2 2026 in Review

AlphaCore Capital increased its Medtronic (MDT) stake by 18% in Q2 2026, buying an estimated $262K and bringing the position to 21,126 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #352.

AlphaCore Capital first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.02M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • AlphaCore Capital held 21,126 shares of Medtronic worth $1.65M as of Q2 2026.
  • AlphaCore Capital bought 3,242 Medtronic shares in Q2 2026, an estimated $262K.
  • Medtronic made up 0.03% of AlphaCore Capital's portfolio in Q2 2026, its #352 holding.
  • AlphaCore Capital first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • AlphaCore Capital's Medtronic position peaked at $2.02M in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.